|
1
|
Gregoire R, Yeung KS, Stadler J, Stern HS,
Kashtan H, Neil G and Bruce WR: Effect of high-fat and low-fiber
meals on the cell proliferation activity of colorectal mucosa. Nutr
Cancer. 15:21–26. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liu S, Zheng R, Zhang M, Zhang S, Sun X
and Chen W: Incidence and mortality of colorectal cancer in China,
2011. Chin J Cancer Res. 27:22–28. 2015.PubMed/NCBI
|
|
3
|
Dawson H, Galván JA, Helbling M, Muller
DE, Karamitopoulou E, Koelzer VH, Economou M, Hammer C, Lugli A and
Zlobec I: Possible role of Cdx2 in the serrated pathway of
colorectal cancer characterized by BRAF mutation, high-level CpG
Island methylator phenotype and mismatch repair-deficiency. Int J
Cancer. 134:2342–2351. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang XT, Xie YB and Xiao Q: siRNA
targeting of Cdx2 inhibits growth of human gastric cancer MGC-803
cells. World J Gastroenterol. 18:1903–1914. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Baba Y, Nosho K, Shima K, Freed E, Irahara
N, Philips J, Meyerhardt JA, Hornick JL, Shivdasani RA, Fuchs CS,
et al: Relationship of CDX2 loss with molecular features and
prognosis in colorectal cancer. Clin Cancer Res. 15:4665–4673.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Saandi T, Baraille F, Derbal-Wolfrom L,
Cattin AL, Benahmed F, Martin E, Cardot P, Duclos B, Ribeiro A,
Freund JN, et al: Regulation of the tumor suppressor homeogene Cdx2
by HNF4α in intestinal cancer. Oncogene. 32:3782–3788. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kim SP, Park JW, Lee SH, Lim JH, Jang BC,
Lee SH, Jang IH, Freund JN, Suh SI, Mun KC, et al: Homeodomain
protein CDX2 regulates COX-2 expression in colorectal cancer.
Biochem Biophys Res Commun. 315:93–99. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kawai H, Tomii K, Toyooka S, Yano M,
Murakami M, Tsukuda K and Shimizu N: Promoter methylation
downregulates CDX2 expression in colorectal carcinomas. Oncol Rep.
13:547–551. 2005.PubMed/NCBI
|
|
9
|
Brabletz T, Spaderna S, Kolb J, Hlubek F,
Faller G, Bruns CJ, Jung A, Nentwich J, Duluc I, Domon-Dell C, et
al: Down-regulation of the homeodomain factor Cdx2 in colorectal
cancer by collagen type I: An active role for the tumor environment
in malignant tumor progression. Cancer Res. 64:6973–6977. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li F, Wang Y, Zhang G, Zhou J, Yang L and
Guan H: Expression and methylation of DNA repair genes in lens
epithelium cells of age-related cataract. Mutat Res 766-767. 31–36.
2014. View Article : Google Scholar
|
|
11
|
Zhang JF, Zhang JG, Kuai XL, Zhang H,
Jiang W, Ding WF, Li ZL, Zhu HJ and Mao ZB: Reactivation of the
homeotic tumor suppressor gene CDX2 by
5-aza-2′-deoxycytidine-induced demethylation inhibits cell
proliferation and induces caspase-independent apoptosis in gastric
cancer cells. Exp Ther Med. 5:735–741. 2013.PubMed/NCBI
|
|
12
|
Wojdacz TK, Hansen LL and Dobrovic A: A
new approach toprimer design for the control of PCR bias in
methylation studies. BMC Res Notes. 1:542008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Padda RS, Gkouvatsos K, Guido M, Mui J,
Vali H and Pantopoulos K: A high-fat diet modulates iron metabolism
but does not promote liver fibrosis in hemochromatotic Hjv¯/¯ mice.
Am J Physiol Gastrointest Liver Physiol. 308:G251–G261. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sugimoto M, Yamaoka Y and Furuta T:
Influence of interleukin polymorphisms on development of gastric
cancer and peptic ulcer. World J Gastroenterol. 16:1188–1200. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gendron FP, Mongrain S, Laprise P, McMahon
S, Dubois CM, Blais M, Asselin C and Rivard N: The CDX2
transcription factor regulates furin expression during intestinal
epithelial cell differentiation. Am J Physiol Gastrointest Liver
Physiol. 290:G310–G318. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mutoh H, Hayakawa H, Sakamoto H and Sugano
K: Homeobox protein CDX2 reduces Cox-2 transcription by
inactivating the DNA-binding capacity of nuclear factor-kappaB. J
Gastroenterol. 42:719–729. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Qin R, Wang NN, Chu J and Wang X:
Expression and significance of homeodomain protein Cdx2 in gastric
carcinoma and precancerous lesions. World J Gastroenterol.
18:3296–3302. 2012.PubMed/NCBI
|
|
18
|
Bai YQ, Yamamoto H, Akiyama Y, Tanaka H,
Takizawa T, Koike M, Yagi O Kenji, Saitoh K, Takeshita K, Iwai T,
et al: Ectopic expression of homeodomain protein CDX2 in intestinal
metaplasia and carcinomas of the stomach. Cancer Lett. 176:47–55.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Asano N, Imatani A, Watanabe T, Fushiya J,
Kondo Y, Jin X, Ara N, Uno K, Iijima K, Koike T, et al: Cdx2
expression and intestinal metaplasia induced by H. Pylori infection
of gastric cells is regulated by NOD1-Mediated innate immune
responses. Cancer Res. 76:1135–1145. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mutoh H, Sakurai S, Satoh K, Tamada K,
Kita H, Osawa H, Tomiyama T, Sato Y, Yamamoto H, Isoda N, et al:
Development of gastric carcinoma from intestinal metaplasia in
Cdx2-transgenic mice. Cancer Res. 64:7740–7747. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mizoshita T, Tsukamoto T, Nakanishi H,
Inada K, Ogasawara N, Joh T, Itoh M, Yamamura Y and Tatematsu M:
Expression of Cdx2 and the phenotype of advanced gastric cancers:
Relationship with prognosis. J Cancer Res Clin Oncol. 129:727–734.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zheng J, Sun X, Wang W and Lu S:
Hypoxia-inducible factor-1α modulates the down-regulation of the
homeodomain protein CDX2 in colorectal cancer. Oncol Rep.
24:97–104. 2010.PubMed/NCBI
|
|
23
|
Soubeyran P, Mallo GV, Moucadel V, Dagorn
JC and Iovanna JL: Overexpression of Cdx1 and Cdx2 homeogenes
enhances expression of the HLA-I in HT-29 cells. Mol Cell Biol Res
Commun. 3:271–276. 2000. View Article : Google Scholar : PubMed/NCBI
|
